Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.B9uuF-Zi.js ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies ...